Back to search

Boston University

Generation of a novel murine model of cardiovascular-kidney metabolic syndrome

Abstract

dc:description.abstract

OBJECTIVE: Cardiovascular-kidney metabolic (CKM) syndrome refers to the collective interactions between metabolic dysfunction, cardiovascular disease (CVD), and chronic kidney disease (CKD). Emerging as a major threat to public health, CKM syndrome is prevalent in more than one in four adults within the US and is responsible for substantial mortality and healthcare burden. The mediators of CKM syndrome have yet to be fully elucidated due to a lack of reliable CKM models. Therefore, we set out to generate a model representing the pathophysiology of CKM syndrome. METHODS: Twenty-eight male C57BL/6J mice were randomized into one of four casein-based diets administered for six weeks: normal diet (ND), 0.2% adenine-enriched diet (AD), 60% high-fat diet (HFD), and a combination of HFD + AD. PAD was induced via hindlimb ischemia as a downstream manifestation of CVD one week prior to diet randomization. Weekly GFR measurements were taken via FITC-Sinistrin clearance. Food intake, weight trends, and serum cholesterol and triglyceride levels were assessed. General (H&E, Picro-Sirius Red, Masson’s Trichrome) and IF (Adipophilin, a marker for non-alcoholic hepatic steatosis) staining was performed for histopathological analysis. RESULTS: Compared to mice on AD, HFD + AD mice demonstrated an attenuated decline of GFR, yet manifested glomerulomegaly and tubulointerstitial fibrosis at a preserved GFR in a manner consistent with clinical CKM. Hypercholesterolemia, liver adipophilin expression, and sub-myocardial fibrosis were also observed in HFD + AD. CONCLUSION: A combination of HFD + AD in mice manifests hallmarks of CKD (reduced GFR, renal fibrosis), metabolic dysfunction (dyslipidemia, glucose intolerance, non-alcoholic hepatic steatosis), and CVD (sub-myocardial fibrosis). The multiorgan phenotypes produced by this model may assist our mechanistic understanding of CKM syndrome and/or test therapeutic efficacy.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Yamamoto, Trent
Advisors dc:contributor.advisor
  • Chitalia, Vipul
  • Kintsurashvili, Ekaterina
ORCID dc:identifier.orcid

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • Attribution-NoDerivatives 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52415

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Yamamoto, Trent. Generation of a novel murine model of cardiovascular-kidney metabolic syndrome. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/52415